Search research articles
Contact Us
Filters
Showing results (41-50 of 275) with videos related to
Page
of 28
Sort By:
Best Practice & Research. Clinical Rheumatology
|
May 19, 2001
How can the risk of long-term consequences of rheumatoid arthritis be reduced?
T Pincus, T Sokka
Clinical and Experimental Rheumatology
|
March 3, 2004
Partial control of Core Data Set measures and Disease Activity Score (DAS) measures of inflammation does not prevent long-term joint damage: evidence from longitudinal observations over 5-20 years
T Pincus, T Sokka
The Journal of Rheumatology
|
July 27, 2001
Quantitative target values of predictors of mortality in rheumatoid arthritis as possible goals for therapeutic interventions: an alternative approach to remission or ACR20 responses?
T Pincus, T Sokka
Clinical and Experimental Rheumatology
|
December 5, 2002
Mortality, course of disease and prognosis of patients with ankylosing spondylitis
J Braun, T Pincus
The Journal of Rheumatology
|
May 1, 1991
Standard self-report questionnaires in routine clinical and research practice--an opportunity for patients and rheumatologists
F Wolfe, T Pincus
Rheumatology (Oxford, England)
|
December 22, 2004
How aggressive should initial therapy for rheumatoid arthritis be?
T Pincus, T Sokka
Clinical and Experimental Rheumatology
|
December 17, 2008
Mortality in rheumatic diseases. Introduction
T Pincus, T Sokka
Clinical and Experimental Rheumatology
|
November 9, 2005
Quantitative joint assessment in rheumatoid arthritis
T Sokka, T Pincus
Clinical and Experimental Rheumatology
|
February 19, 2004
A historical perspective concerning population-based and clinical studies of early arthritis and early rheumatoid arthritis
T Sokka, T Pincus
Rheumatology (Oxford, England)
|
March 16, 2006
Should aggressive therapy for rheumatoid arthritis require early use of weekly low-dose methotrexate, as the first disease-modifying anti-rheumatic drug in most patients?
T Pincus, T Sokka
Page
of 28
Search research articles
Search
Showing results (41-50 of 275) with videos related to
Sort By:
Page
of 28
Best Practice & Research. Clinical Rheumatology
|
May 19, 2001
How can the risk of long-term consequences of rheumatoid arthritis be reduced?
T Pincus, T Sokka
Clinical and Experimental Rheumatology
|
March 3, 2004
Partial control of Core Data Set measures and Disease Activity Score (DAS) measures of inflammation does not prevent long-term joint damage: evidence from longitudinal observations over 5-20 years
T Pincus, T Sokka
The Journal of Rheumatology
|
July 27, 2001
Quantitative target values of predictors of mortality in rheumatoid arthritis as possible goals for therapeutic interventions: an alternative approach to remission or ACR20 responses?
T Pincus, T Sokka
Clinical and Experimental Rheumatology
|
December 5, 2002
Mortality, course of disease and prognosis of patients with ankylosing spondylitis
J Braun, T Pincus
The Journal of Rheumatology
|
May 1, 1991
Standard self-report questionnaires in routine clinical and research practice--an opportunity for patients and rheumatologists
F Wolfe, T Pincus
Rheumatology (Oxford, England)
|
December 22, 2004
How aggressive should initial therapy for rheumatoid arthritis be?
T Pincus, T Sokka
Clinical and Experimental Rheumatology
|
December 17, 2008
Mortality in rheumatic diseases. Introduction
T Pincus, T Sokka
Clinical and Experimental Rheumatology
|
November 9, 2005
Quantitative joint assessment in rheumatoid arthritis
T Sokka, T Pincus
Clinical and Experimental Rheumatology
|
February 19, 2004
A historical perspective concerning population-based and clinical studies of early arthritis and early rheumatoid arthritis
T Sokka, T Pincus
Rheumatology (Oxford, England)
|
March 16, 2006
Should aggressive therapy for rheumatoid arthritis require early use of weekly low-dose methotrexate, as the first disease-modifying anti-rheumatic drug in most patients?
T Pincus, T Sokka
Page
of 28